RadNet, Inc. (RDNT)
70.34
+0.08
(+0.11%)
USD |
NASDAQ |
Oct 23, 16:00
70.32
-0.02
(-0.04%)
After-Hours: 20:00
RadNet Enterprise Value : 7.288B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.288B |
| October 22, 2026 | 7.281B |
| October 21, 2026 | 7.136B |
| October 20, 2026 | 7.233B |
| October 19, 2026 | 7.204B |
| October 16, 2026 | 7.167B |
| October 15, 2026 | 7.293B |
| October 14, 2026 | 7.195B |
| October 13, 2026 | 7.380B |
| October 12, 2026 | 7.378B |
| October 09, 2026 | 7.333B |
| October 08, 2026 | 7.120B |
| October 07, 2026 | 7.152B |
| October 06, 2026 | 7.283B |
| October 05, 2026 | 7.306B |
| October 02, 2026 | 7.255B |
| October 01, 2026 | 7.080B |
| September 30, 2026 | 7.178B |
| September 29, 2026 | 7.312B |
| September 28, 2026 | 7.403B |
| September 25, 2026 | 7.323B |
| September 24, 2026 | 7.364B |
| September 23, 2026 | 7.513B |
| September 22, 2026 | 7.570B |
| September 21, 2026 | 7.471B |
| Date | Value |
|---|---|
| September 18, 2026 | 7.733B |
| September 17, 2026 | 7.873B |
| September 16, 2026 | 7.716B |
| September 15, 2026 | 7.821B |
| September 14, 2026 | 7.693B |
| September 11, 2026 | 7.693B |
| September 10, 2026 | 7.598B |
| September 09, 2026 | 7.329B |
| September 08, 2026 | 7.416B |
| September 04, 2026 | 7.553B |
| September 03, 2026 | 7.624B |
| September 02, 2026 | 7.709B |
| September 01, 2026 | 7.695B |
| August 31, 2026 | 7.719B |
| August 28, 2026 | 7.624B |
| August 27, 2026 | 7.683B |
| August 26, 2026 | 7.770B |
| August 25, 2026 | 7.801B |
| August 24, 2026 | 7.630B |
| August 21, 2026 | 7.797B |
| August 20, 2026 | 7.815B |
| August 19, 2026 | 7.697B |
| August 18, 2026 | 7.562B |
| August 17, 2026 | 7.727B |
| August 14, 2026 | 7.760B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Castle Biosciences, Inc. | 779.07M |
| Lumexa Imaging Holdings, Inc. | 2.026B |
| Quest Diagnostics, Inc. | 32.49B |
| Labcorp Holdings, Inc. | 33.25B |
| OPKO Health, Inc. | 1.313B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.25M |
| Revenue (Quarterly) | 622.72M |
| Total Expenses (Quarterly) | 615.19M |
| EPS Diluted (Quarterly) | 0.0956 |
| Gross Profit Margin (Quarterly) | 7.89% |
| Profit Margin (Quarterly) | 3.25% |
| Earnings Yield | -0.39% |
| Operating Earnings Yield | 1.93% |
| Normalized Earnings Yield | -0.0196 |